Home Support ISMP Newsletters Webinars Report Medication Error to ISMP Educational Resources ISMP Online Store Consulting Services FAQ Tools and Resources About ISMP Contact Us
Print This Page SitemapISMP Facebook
Site Search by PicoSearch. Help

Updated: ISMP's List of High-Alert Medications

From the August 9, 2007 issue

Based on a 2007 practitioner survey and review by ISMP and other medication safety experts, ISMP’s List of High-Alert Medications has been updated (see the PDF version of the newsletter for a list). Additions to the list include: epoprostenol (Flolan) IV, oxytocin IV, promethazine IV, and sterile water for injection, inhalation, and irrigation (excluding pour bottles) in containers of 100 mL or more. Warfarin, heparin, low-molecular-weight heparin, thrombolytics, and glycoprotein IIb/IIIa inhibitors were moved to a new category, antithrombotic agents, to which Factor Xa inhibitors and direct thrombin inhibitors were added. Amiodarone and lidocaine were also moved to a new category, anti-arrhythmics IV. Nesiritide was removed from the list due to a significant decline in use.

Click here to to see the list.

Resources
Acute Care Main Page
Current Issue
Past Issues
Recent articles
Survey Results
Action Agendas - Free CE's
Hazard Alerts
Subscribe
Contest Winners
Newsletter Editions
Acute Care
Community/Ambulatory
Nursing
Consumer
Home | Contact UsEmployment  | Legal Notices | Privacy Policy | Help Support ISMP
  Med-ERRS |   ISMP Canada |  ISMP Spain | ISMP Brasil | International Group | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2012 Institute for Safe Medication Practices. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.

Search only trustworthy HONcode health websites: